Riskpilot← Back to searchSign inGet full accessTermino C 12667 AB
ABDissolvedOrg 5569371718Wholesale of pharmaceutical and medical goods · NACE 4646Est. 20130 employees
Revenue 2023
SEK 2,4M
+26% vs 2022
EBITDA margin
36.4%
+363% vs 2022
Equity ratio
54.8%
Financial strength
Net profit 2023
SEK 505K
+73% vs 2022
| Revenue | SEK 2,4M | +26% |
| EBITDA | SEK 877K | +363% |
| Net profit | SEK 505K | +73% |
| Total assets | SEK 1,1M | +75% |
| Equity | SEK 605K | +73% |
| Employees | 0 | — |
Legal name
Termino C 12667 AB
Org number
5569371718
Legal form
Aktiebolag
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
11 juli 2013
Share capital
SEK 50 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2023-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamoten suppleanten
Company purpose
Aktiebolaget skall bedriva förvaltning av värdepapper samt därmed jämförlig verksamhet.
Address
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| Revenue | 1 724 | 1 362 | 2 114 | 1 915 | 2 408 |
| Staff expenses | — | — | — | −1 250 | −1 040 |
| EBITDA | 350 | 260 | 571 | 189 | 877 |
| Depreciation & amort. | −5 | −5 | −5 | −5 | −5 |
| EBIT | 345 | 255 | 566 | 184 | 872 |
| Net financials | −3 | −3 | −4 | −3 | −3 |
| Profit before tax | 246 | 252 | 462 | 377 | 644 |
| Tax | −61 | −60 | −103 | −84 | −140 |
| Net profit | 185 | 192 | 359 | 292 | 505 |
| Item | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| Total assets | 556 | 680 | 991 | 630 | 1 103 |
| Equity | 257 | 449 | 458 | 350 | 605 |
| Long-term debt | 0 | 0 | 0 | — | — |
| Short-term debt | 204 | 136 | 338 | 280 | 273 |
| Total debt | 204 | 136 | 338 | 280 | 273 |
EBITDA margin
36.4%
This company
15.8%
Market median
+130% vs market
20192023
Equity ratio
54.8%
This company
38.2%
Market median
+43% vs market
20192023
Return on equity
83.5%
This company
18.4%
Market median
+354% vs market
20192023
Net profit margin
21.0%
This company
8.1%
Market median
+159% vs market
20192023
Asset turnover
2.18×
This company
1.12×
Market median
+95% vs market
20192023
Debt / equity
0.82×
This company
0.62×
Market median
+32% vs market
20192023
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Bolagsverket / SCB · Period 2019-01-01 – 2019-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2025 | |
| Board of Directors | 2025 | |
| Former (2) | ||
| Deputy Board Member | 2022 – 2025 | |
| Board of Directors | 2022 – 2025 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Termino C 12667 AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Eva Kristina Einarsson | Deputy Board Member | 0 companies |
| Anders Jakob Lindquist | Deputy Board Member | 0 companies |
| Hans Fredrik Einarsson | Board of Directors | 0 companies |
| Torbjörn Nordberg | Board of Directors | 0 companies |